Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
47.66
-1.30 (-2.65%)
Nov 21, 2024, 11:09 AM EST - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $2.50 billion as of November 21, 2024. Its market cap has increased by 726.15% in one year.
Market Cap
2.50B
Enterprise Value
1.93B
1-Year Change
726.15%
Ranking
Category
Stock Price
$47.66
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $2.50B, an increase of 307.54%. That is a compound annual growth rate of 50.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.57B | 418.86% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 2.60B |
| QuidelOrtho | 2.59B |
| Amneal Pharmaceuticals | 2.58B |
| Belite Bio | 2.55B |
| Catalyst Pharmaceuticals | 2.53B |
| Privia Health Group | 2.52B |
| Scholar Rock Holding | 2.51B |
| Iovance Biotherapeutics | 2.50B |